The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Mechanisms of Integrin–Vascular Endothelial Growth Factor Receptor Cross-Activation in Angiogenesis
Open accessAbstract
The functional responses of endothelial cells are dependent on signaling from peptide growth factors and the cellular adhesion receptors, integrins. These include cell adhesion, migration, and proliferation, which, in turn, are essential for more complex processes such as formation of the endothelial tube network during angiogenesis. This study identifies the molecular requirements for the cross-activation between β 3 integrin and tyrosine kinase receptor 2 for vascular endothelial growth factor (VEGF) receptor (VEGFR-2) on endothelium. The relationship between VEGFR-2 and β 3 integrin appears to be synergistic, because VEGFR-2 activation induces β 3 integrin tyrosine phosphorylation, which, in turn, is crucial for VEGF-induced tyrosine phosphorylation of VEGFR-2. We demonstrate here that adhesion- and growth factor–induced β 3 integrin tyrosine phosphorylation are directly mediated by c-Src. VEGF-stimulated recruitment and activation of c-Src and subsequent β 3 integrin tyrosine phosphorylation are critical for interaction between VEGFR-2 and β 3 integrin. Moreover, c-Src mediates growth factor–induced β 3 integrin activation, ligand binding, β 3 integrin-dependent cell adhesion, directional migration of endothelial cells, and initiation of angiogenic programming in endothelial cells. Thus, the present study determines the molecular mechanisms and consequences of the synergism between 2 cell surface receptor systems, growth factor receptor and integrins, and opens new avenues for the development of pro- and antiangiogenic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,482
Src family kinases are required for integrin but not PDGFR signal transduction
Klinghoffer, R. A., Sachsenmaier, C., Cooper, J. A., & Soriano, P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2459 · Cited by 731
Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2
Soldi, R., Mitola, S., Strasly, M., Defilippi, P., Tarone, G., & Bussolino, F. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.882 · Cited by 626
Ingber, D. E. (2002) · Circulation Research · doi:10.1161/01.res.0000039537.73816.e5 · Cited by 621
c-Src and cooperating partners in human cancer
Ishizawar, R., & Parsons, S. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.001 · Cited by 617
SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling
Blake, R. A., Broome, M. A., Liu, X., Wu, J., Gishizky, M., Sun, L., & Courtneidge, S. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.9018-9027.2000 · Cited by 584
Weis, S., Cui, J., Barnes, L., & Cheresh, D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408130 · Cited by 477
Integrin and Growth Factor Receptor Crosstalk
Eliceiri, B. P. (2001) · Circulation Research · doi:10.1161/hh2401.101084 · Cited by 395
Gutheil, J. C., Campbell, T. N., Pierce, P. R., Watkins, J. D., Huse, W. D., Bodkin, D., & Cheresh, D. A. (2000) · PubMed · Cited by 369
c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption
Tanaka, S., Amling, M., Neff, L., Peyman, A., Uhlmann, E., Levy, J. B., & Baron, R. (1996) · Nature · doi:10.1038/383528a0 · Cited by 288
Interactions between growth factor receptors and adhesion molecules: breaking the rules
Comoglio, P. M., Boccaccio, C., & Trusolino, L. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00096-6 · Cited by 254
Platelet and osteoclast β 3 integrins are critical for bone metastasis
Bakewell, S. J., Nestor, P., Prasad, S., Tomasson, M. H., Dowland, N., Mehrotra, M., Scarborough, R., Kanter, J., Abe, K., Phillips, D., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234372100 · Cited by 233
Integrin signaling is critical for pathological angiogenesis
Mahabeleshwar, G. H., Feng, W., Phillips, D. R., & Byzova, T. V. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060807 · Cited by 206
Self-citationIntegrins: Molecular targets in cancer therapy
Tucker, G. C. (2006) · Current Oncology Reports · doi:10.1007/s11912-006-0043-3 · Cited by 203
Molecular and mechanical synergy: cross-talk between integrins and growth factor receptors*1
Ross, R. S. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.027 · Cited by 160
Vascular Integrins in Tumor Angiogenesis: Mediators and Therapeutic Targets
Alghisi, G. C., & Rüegg, C. (2006) · Endothelium · doi:10.1080/10623320600698037 · Cited by 159
Maaser, K., Wolf, K., Klein, C. E., Niggemann, B., Zänker, K. S., Bröcker, E., & Friedl, P. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.10.3067 · Cited by 128
Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability
Criscuoli, M. L., Nguyen, M. T. N., & Eliceiri, B. P. (2004) · Blood · doi:10.1182/blood-2004-06-2246 · Cited by 121
Phosphorylation of β3 Integrin Controls Ligand Binding Strength
Datta, A., Huber, F., & Boettiger, D. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109536200 · Cited by 92
Blystone, S. D., Williams, M. P., Slater, S. E., & Brown, E. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28757 · Cited by 86
de Virgilio, M., Kiosses, W. B., & Shattil, S. J. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200402064 · Cited by 83
Cooperation between VEGF and β3 integrin during cardiac vascular development
Weis, S. M., Lindquist, J. N., Barnes, L. A., Lutu-Fuga, K. M., Cui, J., Wood, M. R., & Cheresh, D. A. (2006) · Blood · doi:10.1182/blood-2005-10-038893 · Cited by 77
Integrin cytoplasmic domains as connectors to the cell's signal transduction apparatus
LaFlamme, S. E., Homan, S. M., Bodeau, A. L., & Mastrangelo, A. M. (1997) · Matrix Biology · doi:10.1016/s0945-053x(97)90003-2 · Cited by 58
Carmeliet, P. (2002) · Nature Medicine · doi:10.1038/nm0102-14 · Cited by 52
Targeting integrins alpha v beta 3 and alpha v beta 5 for blocking tumor-induced angiogenesis.
Kumar, C. C., Armstrong, L., Yin, Z., Malkowski, M. G., Maxwell, E., He, L., Yaremko, B., Liu, M., Varner, J. A., Smith, E., et al. (2000) · PubMed · Cited by 37
Chandhoke, S. K., Williams, M., Schaefer, E., Zorn, L., & Blystone, S. D. (2004) · Journal of Cell Science · doi:10.1242/jcs.00987 · Cited by 33
Antiangiogenic Therapy Decreases Integrin Expression in Normalized Tumor Blood Vessels
Yao, V. J., Ozawa, M. G., Varner, A. S., Kasman, I. M., Chanthery, Y. H., Pasqualini, R., Arap, W., & McDonald, D. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1824 · Cited by 29
Cited by
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Tumor angiogenesis: molecular pathways and therapeutic targets
Weis, S. M., & Cheresh, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2537 · Cited by 1,736
Targeting integrin pathways: mechanisms and advances in therapy
Pang, X., He, X., Qiu, Z., Zhang, H., Xie, R., Liu, Z., Gu, Y., Zhao, N., Xiang, Q., & Cui, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01259-6 · Cited by 1,275
Blood-brain barrier tight junction permeability and ischemic stroke
Sandoval, K. E., & Witt, K. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.005 · Cited by 964
Claesson‐Welsh, L., & Welsh, M. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12019 · Cited by 868
Metadata
- Authors
- Mahabeleshwar, G. H., Feng, W., Reddy, K., Plow, E. F., & Byzova, T. V.
- Venue
- Circulation Research
- Published
- 2007-09-14
- Volume
- 101
- Issue
- 6
- Pages
- 570-580
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2099487193
- Cited by
- 298
- References
- 28
- FWCI
- 11.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.